1. South Korea Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Shinhung Co., Ltd

Shinhung Co., Ltd

KKRX:004080
14,400.00
KRW
+10.00
(+0.07%)
591.27EPS
24.09P/E
129.07BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
12,975.02
13,037.73
13,158.77
13,027.99
12,697.08
12,735.07
12,939.74
12,217.61
13,374.16
12,580.65
11,938.02
10,781.62
11,306.08
11,394.53
Basic EPS, GAAP
146
708
310
121
332
320
71
1,302
1,418
901
980
554
311
576.52
Free Cash Flow per Basic Share
410.64
982.22
-1,353.71
767.71
128.01
-216.49
-1,609.01
-795.65
102.72
102.2
176.22
598.39
-175.48
-603.42
Dividend per Share
119.52
120.19
121.08
120.41
121.03
120.63
120.56
120.31
200.84
239.84
259.63
264.67
282.96
139.46
Book Value per Share
8,131.9
8,679.57
8,885.52
8,874.43
9,053.16
9,149.55
8,395.71
9,622.9
10,782.66
11,398.27
12,063.93
12,242.03
12,213.41
12,559.67
Tangible Book Value per Share
7,880.25
8,417.86
8,653.38
8,728.81
8,802.69
8,910.46
8,211.76
9,464.03
10,629.5
11,204.73
11,920.45
12,130.37
12,130.88
12,488.35
Basic Weighted Avg Shares
10
10
10
10
10
10
10
10
9
9
9
9
9
9
Sales/Revenue/Turnover
123,567
124,180
125,395
124,367
121,147
121,545
123,013
116,652
126,853
118,177
112,443
101,756
102,607
105,886
Operating Margin (%)
2.19
4.9
5.2
3.4
3.33
0.91
1.32
2.71
10.28
8.85
10.1
6.17
6.91
8.61
Depreciation Expense
3,633
3,086
2,881
2,800
2,987
3,040
2,906
2,804
3,048
2,878
2,877
3,233
3,853
3,792
Net Income, GAAP
1,390
6,743
2,954
1,155
3,168
3,054
675
12,431
13,450
8,464
9,231
5,229
2,822
5,357
Effective Tax Rate (%)
60.32
20.36
35.73
46.71
36.69
39.45
47.38
28.49
33.71
18.33
22.95
26.23
40.15
23.6
Profit Margin (%)
1.13
5.43
2.36
0.93
2.61
2.51
0.55
10.66
10.6
7.16
8.21
5.14
2.75
5.06
Working Capital
15,460
20,832
6,778
9,915
11,239
16,723
5,449
10,839
17,857
21,919
25,859
25,771
30,006
33,105
LT Debt
1,546
1,016
636
535
387
848
10,748
571
997
759
651
1,281
2,469
2,000
Total Equity
77,892
82,948
84,847
84,683
86,367
87,305
80,128
91,902
101,417
106,863
113,891
116,161
116,001
117,379
Return on Invested Capital (%)
0.99
4.64
3.86
2.01
2.37
0.63
0.8
2.08
7.87
7.53
7.44
3.86
3.46
5.3
Return on Capital (%)
1.97
7.42
3.44
1.57
3.39
3.34
0.99
11.52
12.72
7.9
8.06
4.59
2.44
4
Return on Common Equity (%)
1.81
8.42
3.53
1.36
3.71
3.52
0.81
14.45
13.91
8.13
8.36
4.56
2.44
4.6

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
8,797
14,407
15,335
LT Borrowings
1,900
1,708
1,517
LT Finance Leases
569
510
483
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
132,185
128,974
129,067

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
61,103
66,417
69,128
Cash, Cash Equivalents & STI
3,275
8,579
9,302
Accounts Receivable, Net
17,091
19,867
19,749
Inventories
34,382
36,754
36,722
Total Current Liabilities
31,097
37,018
36,023
Payables & Accruals
- -
- -
- -
ST Debt
8,797
14,407
15,335
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.35%
4.83%
-0.14%
Free Cash Flow
15.13%
14.13%
-128.2%
Net Income, GAAP
166.44%
-21.84%
-46.02%
Sales/Revenue/Turnover
-1.86%
-2.32%
0.84%
Total Cash Common Dividend
9.72%
19.52%
2.8%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
26,251
24,981
23,837
26,687
101,756
2025
23,616
24,542
24,099
30,350
102,607
2026
25,155
26,282
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130
160
111
152.23
554
2025
30
204
105
-33.29
311
2026
82.95
425
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
131.85
- -
264.67
2025
- -
- -
140.97
- -
282.96
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yong-Ik Lee
Full Time Employees
208
Sector
Health technology
Industry
Medical specialties
Address
Shinhung Building Seoul SL South Korea 04510
IPO Date
Feb 8, 1991
Website
shinhung.co.kr
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Shinhung Co., Ltd. specializes in the production and distribution of a broad array of dental instruments and supplies, catering to the South Korean market and numerous international regions including Japan, Iran, the UK, Canada, and Africa. Their extensive portfolio encompasses advanced implant systems, dental unit chairs and associated operatory equipment, sophisticated X-ray apparatus, sterilization autoclaves, and essential consumables like disposable needles. The company also provides dental alloys, porcelain powders, laboratory essentials, and a variety of cabinet solutions, alongside other vital equipment such as compressors and mixers. Furthermore, they extend financial support options tailored for dental practitioners. Established in 1955, Shinhung Co., Ltd. maintains its primary corporate office in Seoul, South Korea, complemented by manufacturing operations in Ansan and Wonju, South Korea, and a representative presence in Shanghai, China. Notably, in July 2025, the company entered into a strategic joint venture with Yuhan Corp. to introduce the "Yuhan Evertis" implant, collaborating on product development, marketing, and sales of dental medical devices and pharmaceuticals.